choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Velcade

Velcade Newsletter
  • <![CDATA[Iberdomide Holds Promise in Phase 3 R/R Myeloma Trial]]> 25 Sep 2025 19:03 GMT

    … degradation and developing new treatment options for patients … a novel class of medicines, called [cereblon E3 … and dexamethasone vs daratumumab, bortezomib (Velcade), and dexamethasone (DVd) … a CELMoD in clinical trials. International Myeloma Foundation. …

  • <![CDATA[New Drug Combo Shows Deeper Responses in Multiple Myeloma]]> 25 Sep 2025 16:12 GMT

    … from the phase 3 trial EXCALIBER-RRMM which … and dexamethasone or Darzalex, Velcade (bortezomib) and dexamethasone. What are … were called immunomodulatory drugs. These medicines work by helping … clinical trials to better understand how new treatments may …

  • <![CDATA[Considering Subsequent Treatment in NDMM After Teclistamab-Based Induction]]> 24 Sep 2025 04:47 GMT

    … sequencing subsequent lines of treatment for patients with newly … induction therapy in the trial, Raab emphasized using … and the Department of Medicine V at the … daratumumab] and lenalidomide [Revlimid], bortezomib [Velcade], and dexamethasone [RVd], are …

  • Bristol Myers says next-gen blood cancer drug hits goal in key study 23 Sep 2025 22:24 GMT

    … tested iberdomide alongside two other drugs, Darzalex and the steroid dexamethasone … widely used treatment combination: Darzalex, dexamethasone and another medicine called Velcade. The trial enrolled …

  • <![CDATA[Dara-Based Regimens Benefit Patients With NDMM Irrespective of Frailty]]> 25 Sep 2025 19:03 GMT

    … ) and MAIA (NCT02252172) trials found that daratumumab (Darzalex … in the CEPHEUS trial, frailty scores at … daratumumab; Darzalex Faspro) plus bortezomib (Velcade), lenalidomide (Revlimid), and … at least 1 serious treatment-emergent adverse effect ( …

  • BMS eyes filings for myeloma 'celmod' iberdomide 24 Sep 2025 13:54 GMT

    … drug iberdomide after reporting positive results in a phase 3 trial … $3.5 billion. Both drugs, acquired when BMS bought … J&J's Velcade (bortezomib), and dexamethasone (DVd), and … degradation and developing new treatment options for patients living …

  • BMS to speak with regulators on mid-stage multiple myeloma success 24 Sep 2025 12:16 GMT

    … a novel class of medicines, called CELMoDs, … a US Food and Drug Administration (FDA) Advisory Committee (AdCom … Currently, initial MM treatment includes Velcade (bortezomib), Revlimid (lenalidomide), and … deserve! The Clinical Trials Arena Excellence Awards …

  • <![CDATA[Treating Multiple Myeloma With Earlier CAR T-Cell Therapy]]> 24 Sep 2025 02:16 GMT

    … , assistant professor of medicine and director of CAR … from the CARTITUDE-4 trial [NCT04181827] of ciltacabtagene … previous treatments with: D-VRd (daratumumab [Darzalex], bortezomib [Velcade], lenalidomide … [PI] and immunomodulatory drug, and be refractory to …

  • <![CDATA[Tecvayli Plus Darzalex Shows Strong Results in Newly Diagnosed Myeloma]]> 23 Sep 2025 20:38 GMT

    … and without bortezomib. Every patient across all treatment groups responded to … Johnson & Johnson Innovative Medicine, said in the news release … stem cell transplant. The trial is sponsored by the German … U.S. Food and Drug Administration in October 2022. …

  • <![CDATA[Alan's Multiple Myeloma Journey: Facing a New Diagnosis]]> 23 Sep 2025 14:10 GMT

    … Medical Center, where he was intubated and started on Revlimid plus Velcade … a rare adverse effect of Velcade therapy, affecting only one-eighth … myeloma diagnosis and treatment, where patients may face multiple medical emergencies while …

Satisfied with the content?

Continue to create your account.